FORLINO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 6.005
AS - Asia 4.168
EU - Europa 3.161
SA - Sud America 654
Continente sconosciuto - Info sul continente non disponibili 284
AF - Africa 177
OC - Oceania 6
Totale 14.455
Nazione #
US - Stati Uniti d'America 5.858
CN - Cina 1.839
SG - Singapore 931
IE - Irlanda 730
VN - Vietnam 517
BR - Brasile 485
HK - Hong Kong 457
RU - Federazione Russa 413
IT - Italia 356
FI - Finlandia 344
DE - Germania 331
UA - Ucraina 249
FR - Francia 198
GB - Regno Unito 158
SE - Svezia 134
ZA - Sudafrica 113
IN - India 104
CA - Canada 72
AR - Argentina 50
BD - Bangladesh 50
MX - Messico 49
BE - Belgio 45
JP - Giappone 40
CO - Colombia 32
IQ - Iraq 31
PL - Polonia 30
AT - Austria 29
EC - Ecuador 29
NL - Olanda 29
TR - Turchia 27
CZ - Repubblica Ceca 24
ID - Indonesia 21
PK - Pakistan 18
ES - Italia 17
SA - Arabia Saudita 17
CL - Cile 16
VE - Venezuela 15
LT - Lituania 13
PY - Paraguay 12
MA - Marocco 11
IR - Iran 10
UZ - Uzbekistan 10
AL - Albania 8
KE - Kenya 8
MY - Malesia 8
RO - Romania 8
ET - Etiopia 7
KG - Kirghizistan 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
DZ - Algeria 6
EG - Egitto 6
KR - Corea 6
PE - Perù 6
PH - Filippine 6
CR - Costa Rica 5
DK - Danimarca 5
GR - Grecia 5
HN - Honduras 5
JM - Giamaica 5
JO - Giordania 5
NP - Nepal 5
AU - Australia 4
BH - Bahrain 4
BO - Bolivia 4
GA - Gabon 4
IL - Israele 4
SN - Senegal 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
GE - Georgia 3
HR - Croazia 3
LB - Libano 3
LV - Lettonia 3
NG - Nigeria 3
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
TH - Thailandia 3
UY - Uruguay 3
AM - Armenia 2
BG - Bulgaria 2
CG - Congo 2
CH - Svizzera 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
MD - Moldavia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TM - Turkmenistan 2
TZ - Tanzania 2
Totale 14.150
Città #
Dallas 874
Dublin 727
Chandler 672
San Jose 542
Ashburn 514
Singapore 507
Hong Kong 449
Beijing 416
Jacksonville 313
Nanjing 302
Ann Arbor 195
Boardman 186
Council Bluffs 186
Los Angeles 176
Ho Chi Minh City 170
Helsinki 140
Hanoi 121
Nanchang 120
Lauterbourg 119
Princeton 116
Munich 115
Lawrence 113
Wilmington 103
Johannesburg 102
Shenyang 99
Medford 98
Changsha 96
Pavia 93
Hebei 83
Shanghai 83
New York 79
Moscow 77
Jiaxing 68
Milan 65
Hangzhou 64
Buffalo 62
Tianjin 57
Redondo Beach 56
Santa Clara 53
Woodbridge 50
São Paulo 48
Turku 47
Brussels 45
Houston 38
Orem 36
Tokyo 34
Columbus 27
Da Nang 25
Frankfurt am Main 25
Montreal 25
Haiphong 24
Chennai 23
Warsaw 22
The Dalles 21
Atlanta 20
Dearborn 20
Nuremberg 20
San Francisco 20
Chicago 19
Seattle 19
Washington 19
Denver 18
Fairfield 18
London 18
Toronto 18
Florence 17
Norwalk 17
Stockholm 17
Brooklyn 16
Belo Horizonte 15
Falkenstein 14
Rio de Janeiro 14
Verona 14
Vienna 14
Hải Dương 13
Quito 13
Baghdad 12
Boston 12
Brno 12
Jinan 12
Amsterdam 11
Des Moines 11
Guangzhou 11
Mexico City 11
Poplar 11
Medellín 10
Mumbai 10
New Delhi 10
Phoenix 10
Riyadh 10
Rome 10
Santiago 10
Biên Hòa 9
Brasília 9
Curitiba 9
Manchester 9
Naples 9
Ninh Bình 9
Olomouc 9
Zhengzhou 9
Totale 9.519
Nome #
Osteogenesis Imperfecta: A Look into the Cerebellum of the Brtl Murine Model 318
A Rare Cause of Lower Extremity Ulcers: Prolidase Deficiency 182
Combined antiresorptive and new anabolic drug approach in osteogenesis imperfecta zebrafish models 181
A quantitative and qualitative method for direct 2-DE analysis of murine cartilage 180
Kinetic and structural evidences on human prolidase pathological mutants suggest strategies for enzyme functional rescue 180
A Mn(II)-Mn(II) center in human prolidase 165
Improved prolidase activity assay allowed enzyme kinetic characterization and faster prolidase deficiency diagnosis 159
Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta. 158
Cartilage histogenesis in a murine model of chondrodysplasia 157
Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family. 154
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 154
Matrix disruptions, growth, and degradation of cartilage with impaired sulfation. 148
Insights from a transgenic mouse model on the role of SLC26A2 in health and disease. 145
Differential response to intracellular stress in the skin from osteogenesis imperfecta Brtl mice with lethal and non lethal phenotype: a proteomic approach 143
In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation. 141
Alpha 1-antitrypsin activity in subarachnoid hemorrhage. 140
Deficient expression of the small proteoglycan decorin in a case of severe/lethal osteogenesis imperfecta. 139
Altered signaling in the G1 phase deregulates chondrocyte growth in a mouse model with proteoglycan undersulfation. 139
Partial rescue of biochemical parameters after hematopoietic stem cell transplantation in a patient with prolidase deficiency due to two novel PEPD mutations 138
Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta 137
Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate 136
Altered cytoskeletal organization characterized lethal but not surviving Brtl+/- mice: insight on phenotypic variability in osteogenesis imperfecta 135
Alteration of proteoglycan sulfation affects bone growth and remodeling. 134
4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion 134
Mutation analysis of five new patients affected by prolidase deficiency: the lack of enzyme activity causes necrosis-like cell death in cultured fibroblasts 133
Characterization of a new PEPD allele causing prolidase deficiency in two unrelated patients: natural-occurrent mutations as a tool to investigate structure-function relationship. 132
A 931 + 2T-->C transition in one COL1A2 allele causes exon 16 skipping in PRO alpha 2(I) mRNA and produces moderately severe OI. 132
Human recombinant prolidase from eukaryotic and prokaryotic sources. Expression, purification, characterization and long-term stability studies. 131
Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification 131
Severely impaired bone material quality in chihuahua zebrafish resembles classical dominant human Osteogenesis Imperfecta 130
Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome 129
Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy 129
Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfecta. 128
The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta 127
A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype 127
Prolidase enzyme is required for extracellular matrix integrity and impacts on postnatal cerebellar cortex development 127
Effect of enamel matrix derivative on human periodontal fibroblasts: proliferation, morphology and root surface colonization. An in vitro study 126
N-acetylcysteine treatment ameliorates the skeletal phenotype of a mouse model of diastrophic dysplasia 125
Loss-of-Function FANCL Mutations Associate with Severe Fanconi Anemia Overlapping the VACTERL Association 124
A base substitution at IVS-19 3'-end splice junction causes exon 20 skipping in pro alpha 2(I) collagen mRNA and produces mild osteogenesis imperfecta. 124
Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations 123
A novel mutation in the sulphate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia. 122
New perspectives on osteogenesis imperfecta. 122
Lack of prolidase causes a bone phenotype both in human and in mouse 122
Glycosaminoglycans show a specific periodic interaction with type I collagen fibrils. 122
Activity of alpha 1-antitrypsin and cigarette smoking in subarachnoid haemorrhage from ruptured aneurysm. 120
Early Fracture Healing is Delayed in the Col1a2 +/G610C Osteogenesis Imperfecta Murine Model 120
N-benzyloxycarbonyl-L-proline: an in vitro inhibitor of prolidase. 119
Optimization of a capillary electrophoretic method to detect and quantify the Gly-Pro dipeptide in complex matrices from long term cultured prolidase deficiency fibroblasts 118
Multiple effects of the Na(+)/H (+) antiporter inhibitor HMA on cancer cells. 117
Loss-of-function FANCL mutations associate with severe fanconi anemia overlapping the VACTERL association 117
Zebrafish Collagen Type I: Molecular and Biochemical Characterization of the Major Structural Protein in Bone and Skin 117
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy. 116
Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes 116
Crtap and p3h1 knock out zebrafish support defective collagen chaperoning as the cause of their osteogenesis imperfecta phenotype 116
A novel chemical chaperone ameliorates osteoblast homeostasis and extracellular matrix in osteogenesis imperfecta 115
Decorin transfection induces proteomic and phenotypic modulation in breast cancer cells 8701-BC. 114
An alpha 2(I) glycine to aspartate substitution is responsible for the presence of a kink in type I collagen in a lethal case of osteogenesis imperfecta. 113
Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta. 111
In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knock-in murine model for classical, dominant osteogenesis imperfecta 110
Identifying the structure of the active sites of human recombinant prolidase 110
Bone cell differentiation and mineralization in wild-type and osteogenesis imperfecta zebrafish are compromised by per- and poly-fluoroalkyl substances (PFAS) 109
Cytoskeleton and nuclear lamina affection in recessive osteogenesis imperfecta: A functional proteomics perspective 108
Knocking out TMEM38B in human foetal osteoblasts hFOB 1.19 by CRISPR/Cas9: A model for recessive OI type XIV 106
Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis. 105
Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling 104
Brittle IV Mouse Model for Osteogenesis imperfecta IV Demonstrates Postpubertal Adaptations to Improve Whole Bone Strength. 100
A standard set of outcome measures for the comprehensive assessment of osteogenesis imperfecta 99
Prolidase deficiency may be reversed by hematopietic stem cell transplantation: CE analysis of dipeptides in urine and monitoring of prolidase activity in blood. 98
MCM5: A new actor in the link between DNA replication and Meier-Gorlin syndrome 98
Alternative splicing in COL1A1 mRNA leads to a partial null allele and two in-frame forms with structural defects in non-lethal osteogenesis imperfecta. 98
XX males SRY negative: a confirmed cause of infertility 97
Absence of Dipeptidyl Peptidase 3 increases oxidative stress and causes bone loss 97
HEM dysplasia and ichthyosis are likely laminopathies and not due to 3beta-hydroxysterol Delta14-reductase deficiency. 96
Novel RPL13 Variants and Variable Clinical Expressivity in a Human Ribosomopathy With Spondyloepimetaphyseal Dysplasia 95
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine 95
Evaluation of the TiMo12Zr6Fe2 alloy for orthopaedic implants: in vitro biocompatibility study by using primary human fibroblasts and osteoblasts 94
Severe (type III) osteogenesis imperfecta due to glycine substitutions in the central domain of the collagen triple helix. 93
Molecular stability of chemically modified collagen triple helices 93
Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors. 92
Characterization of stress response in human retinal epithelial cells. 92
PRKACB and Carney complex 92
Steady-state and pulse-chase analyses of fibrillar collagen 92
Osteogenesis imperfecta and type I collagen mutations. A lethal variant caused by a Gly910->Ala substitution in the a1(I) chain. 91
More bone with less minerals? The effects of dietary phosphorus on the post-cranial skeleton in zebrafish 91
Consortium of Osteogenesis Imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. 90
The administration of exogenous HSP47 as a collagen-specific therapeutic approach 89
Targeting cellular stress in vitro improves osteoblast homeostasis, matrix collagen content and mineralization in two murine models of osteogenesis imperfecta 89
Zebrafish: A Resourceful Vertebrate Model to Investigate Skeletal Disorders 88
Identification of potential non-invasive biomarkers in diastrophic dysplasia 87
Osteogenesis imperfecta 87
Phenotypic characterization of immortalized chondrocytes from a desbuquois dysplasia type 1 mouse model: A tool for studying defects in glycosaminoglycan biosynthesis 87
Use of the Cre/Lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice. 86
Paternal mosaicism for a COL1A1 dominant mutation (alpha 1 Ser-415) causes recurrent osteogenesis imperfecta. 86
Deletions of the PRKAR1A locus at 17q24.2-q24.3 in Carney complex: genotype-phenotype correlations and implications for genetic testing. 86
Prolidase Deficiency: case reports of two Argentinian brothers. 84
Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects. 84
Osteoblasts mineralization and collagen matrix are conserved upon specific Col1a2 silencing 84
Compression Fractures and Partial Phenotype Rescue With a Low Phosphorus Diet in the Chihuahua Zebrafish Osteogenesis Imperfecta Model 84
Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice 83
Totale 11.941
Categoria #
all - tutte 58.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.771


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022533 0 13 10 12 10 6 14 40 29 14 80 305
2022/20231.938 186 180 12 151 202 156 7 114 837 18 48 27
2023/2024743 106 137 26 39 66 168 18 65 10 33 39 36
2024/20252.251 70 143 70 60 91 93 98 148 575 79 270 554
2025/20265.894 410 623 909 640 603 231 936 296 489 409 217 131
2026/2027301 105 196 0 0 0 0 0 0 0 0 0 0
Totale 14.455